A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : hAR / human androgen receptor

[Related PubMed/MEDLINE]
Total Number of Papers: 108
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   hAR  (>> Co-occurring Abbreviation)
Long Form:   human androgen receptor
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2017 A Practical Guide to Molecular Docking and Homology Modelling for Medicinal Chemists. RMSD
2017 Computational study involving identification of endocrine disrupting potential of herbicides: Its implication in TDS and cancer progression in CRPC patients. CRPC, EDCs, TDS
2016 Predicting anti-androgenic activity of bisphenols using molecular docking and quantitative structure-activity relationships. MLR, nROH, QSAR
2016 The ability of the YAS and AR CALUX assays to detect the additive effects of anti-androgenic fungicide mixtures. AR CALUX, YAS
2014 1,2-Dibromo-4-(1,2 dibromoethyl) cyclohexane (TBECH)-mediated steroid hormone receptor activation and gene regulation in chicken LMH cells. cAR, qRT-PCR, zAR
2014 Assessment of combined antiandrogenic effects of binary parabens mixtures in a yeast-based reporter assay. EDCs, iPrP, MeP, NOEC, nPrP, PeP
2014 Assessment of estrogenic and anti-androgenic activities of the mycotoxin zearalenone and its metabolites using in vitro receptor-specific bioassays. ZAN, ZEN
2014 Development and assessment of a novel Arxula adeninivorans androgen screen (A-YAS) assay and its application in analysis of cattle urine. DHT, GAA, HREs
2013 Dual-color bioluminescent bioreporter for forensic analysis: evidence of androgenic and anti-androgenic activity of illicit drugs. AAS, anti, BL
10  2013 Hormonal effects of tetrabromobisphenol A using a combination of in vitro and in vivo assays. TBBPA, VTG
11  2011 Evaluation of androgenic activity of nutraceutical-derived steroids using mammalian and yeast in vitro androgen bioassays. MMTV, MS, RP
12  2011 Length of the human androgen receptor glutamine tract determines androgen sensitivity in vivo. DHT, SV
13  2011 The androgen receptor and its use in biological assays: looking toward effect-based testing and its applications. ---
14  2010 Anti-androgenic endocrine disrupting activities of chlorpyrifos and piperophos. StAR
15  2010 Effect of anabolic-androgenic steroids and glucocorticoids on the kinetics of hAR and hGR nucleocytoplasmic translocation. AAS, ANE, COR, DEX, DHT, hGR, MET, NAN, NHRs, OXA, TEST
16  2009 Detection of anabolic steroids in dietary supplements: the added value of an androgen yeast bioassay in parallel with a liquid chromatography-tandem mass spectrometry screening method. yEGFP
17  2009 Diastereomers of the brominated flame retardant 1,2-dibromo-4-(1,2 dibromoethyl)cyclohexane induce androgen receptor activation in the hepg2 hepatocellular carcinoma cell line and the lncap prostate cancer cell line. PSA
18  2009 Validation and application of a yeast bioassay for screening androgenic activity in calf urine and feed. yEGFP
19  2008 A new highly androgen specific yeast biosensor, enabling optimisation of (Q)SAR model approaches. RAP, yEGFP
20  2008 A sensitive recombinant cell-based bioluminescent assay for detection of androgen-like compounds. ARE, BL
21  2008 Androgen receptor-mediated apoptosis is regulated by photoactivatable androgen receptor ligands. DHT, TDPQ
22  2008 Profiling of benzophenone derivatives using fish and human estrogen receptor-specific in vitro bioassays. BP, hERalpha, rtERalpha, VTG
23  2008 RNA-binding protein hoip accelerates polyQ-induced neurodegeneration in Drosophila. SBMA
24  2007 A naturally occurring mutation in the human androgen receptor of a subject with complete androgen insensitivity confers binding and transactivation by estradiol. ARA70, CAIS, WT
25  2007 Alien interacts with the human androgen receptor and inhibits prostate cancer cell growth. CPA
26  2007 Competitive binding comparison of endocrine-disrupting compounds to recombinant androgen receptor from fathead minnow, rainbow trout, and human. EDCs, EDSTAC, fhAR, rtAR
27  2007 Hormonal activity of polycyclic musks evaluated by reporter gene assay. ADBI, AHMI, AHTN, ATII, DPMI, hERalpha, HHCB, hTR, PCMs
28  2006 Androgen receptor activities of p,p'-DDE, fenvalerate and phoxim detected by androgen receptor reporter gene assay. AR, CV, DDE, DHT, GR
29  2006 Androgen receptor mutations are associated with Gleason score in localized prostate cancer. ---
30  2006 Comparison of androgen receptor CAG and GGN repeat length polymorphism in humans and apes. CAG, CAG
31  2006 Complex regulation of human androgen receptor expression by Wnt signaling in prostate cancer cells. PCa
32  2006 Efficient recombination-based methods for bacterial artificial chromosome fusion and mutagenesis. BAC, BACs
33  2005 A new recombinant cell-based bioluminescent assay for sensitive androgen-like compound detection. ARE, EDC
34  2005 Differential effects of phthalate esters on transcriptional activities via human estrogen receptors alpha and beta, and androgen receptor. hERalpha, hERbeta
35  2005 Evaluation of androgen receptor transcriptional activities of bisphenol A, octylphenol and nonylphenol in vitro. APs, BPA, DHT, NP, OP
36  2005 Polymorphisms of human androgen receptor (hAR) gene in prostate cancer cell lines PC-EW and PC-OR. ---
37  2004 Effect of organochlorine pesticides on human androgen receptor activation in vitro. OCs
38  2004 Estrogenic and anti-androgenic activity of nitrophenols in diesel exhaust particles (DEP). DEP, hER
39  2004 Screening for estrogen and androgen receptor activities in 200 pesticides by in vitro reporter gene assays using Chinese hamster ovary cells. BHC, hER
40  2004 Screening of some anti-androgenic endocrine disruptors using a recombinant cell-based in vitro bioassay. ED
41  2003 Effects of a diphenyl ether-type herbicide, chlornitrofen, and its amino derivative on androgen and estrogen receptor activities. CNP-amino
42  2003 Interactions of androgens, green tea catechins and the antiandrogen flutamide with the external glucose-binding site of the human erythrocyte glucose transporter GLUT1. DHEA, ECG, EGCG, LBD
43  2003 Mutation of the androgen receptor at amino acid 708 (Gly-->Ala) abolishes partial agonist activity of steroidal antiandrogens. CPA, LBD, LBP
44  2003 The use of androgen receptor amino/carboxyl-terminal interaction assays to investigate androgen receptor gene mutations in subjects with varying degrees of androgen insensitivity. AIS, LBD, TIF2
45  2002 Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila. SBMA
46  2002 Evaluation of androgenic bioactivity in human serum by recombinant cell line: preliminary results. CHO, DHEA, DHT
47  2002 Stabilization of androgen receptor protein is induced by agonist, not by antagonists. BIC, DHT
48  2001 Androgen receptor gene mutation associated with complete androgen insensitivity syndrome and Sertoli cell adenoma. CAIS
49  2001 Antimineralocorticoid 11beta-substituted spirolactones exhibit androgen receptor agonistic activity: a structure function study. hMR, LBD
50  2001 c-Jun potentiates the functional interaction between the amino and carboxyl termini of the androgen receptor. AF-2
51  2001 Cytochrome c oxidase subunit Vb interacts with human androgen receptor: a potential mechanism for neurotoxicity in spinobulbar muscular atrophy. CoxVb, polyGln, SBMA
52  2001 Masculinization of female mosquitofish in Kraft mill effluent-contaminated Fenholloway River water is associated with androgen receptor agonist activity. hGR, PME
53  2001 Participation of critical residues from the extreme C-terminal end of the human androgen receptor in the ligand binding function. ---
54  2001 Recombinant expression and purification of human androgen receptor in a baculovirus system. ---
55  2000 Androgen receptor gene mutation identified by PCR-SSCP and sequencing in 4 patients with complete androgen insensitivity syndrome. CAIS
56  2000 Androgen receptor gene mutations do not occur in ovarian cancer. ---
57  2000 Androgen receptor nuclear translocation is facilitated by the f-actin cross-linking protein filamin. ---
58  2000 c-Jun targets amino terminus of androgen receptor in regulating androgen-responsive transcription. TIF-2
59  2000 Effects of isosteric pyridone replacements in androgen receptor antagonists based on 1,2-dihydro- and 1,2,3,4-tetrahydro-2,2-dimethyl-6-trifluoromethyl-8-pyridono[5,6-g]quin olines. ---
60  2000 Environmental polycyclic aromatic hydrocarbons affect androgen receptor activation in vitro. DMBA, PAHs, TCDD
61  2000 Specific recognition of androgens by their nuclear receptor. A structure-function study. LBD, PR
62  2000 Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations. ---
63  1999 4-Alkyl- and 3,4-dialkyl-1,2,3,4-tetrahydro-8-pyridono[5,6-g]quinolines: potent, nonsteroidal androgen receptor agonists. ---
64  1999 Androgen receptor polymorphisms: association with prostate cancer risk, relapse and overall survival. DFS, OS, RR
65  1999 Discordant measures of androgen-binding kinetics in two mutant androgen receptors causing mild or partial androgen insensitivity, respectively. AIS, MB
66  1999 Malignant transformation of human prostatic epithelium is associated with the loss of androgen receptor immunoreactivity in the surrounding stroma. ---
67  1999 Molecular characterisation of a NADH ubiquinone oxidoreductase subunit 5 from Schistosoma mansoni and inhibition of mitochondrial respiratory chain function by testosterone. ---
68  1999 Nonsteroidal androgen receptor agonists based on 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one. ---
69  1999 RFG (ARA70, ELE1) interacts with the human androgen receptor in a ligand-dependent fashion, but functions only weakly as a coactivator in cotransfection assays. GST, HBD, MMTV, RFG
70  1999 Switching androgen receptor antagonists to agonists by modifying C-ring substituents on piperidino[3,2-g]quinolinone. ---
71  1998 c-Fos dimerization with c-Jun represses c-Jun enhancement of androgen receptor transactivation. hKLK2
72  1998 New nonsteroidal androgen receptor modulators based on 4-(trifluoromethyl)-2(1H)-pyrrolidino[3,2-g] quinolinone. ---
73  1998 Phorbol ester causes ligand-independent activation of the androgen receptor. ARE, CAT, hGR, PKC, rPR, TPA
74  1998 Quantitation of androgen receptor messenger RNA from genital skin fibroblasts by reverse transcription--competitive polymerase chain reaction. GAPDH, GSF, RT-PCR
75  1998 Synthesis and biological activity of a novel series of nonsteroidal, peripherally selective androgen receptor antagonists derived from 1,2-dihydropyridono[5,6-g]quinolines. ---
76  1997 4-Methyl-3-oxo-4-aza-5alpha-androst-1-ene-17beta-N-aryl-carboxamides: an approach to combined androgen blockade [5alpha-reductase inhibition with androgen receptor binding in vitro]. 5AR, PC
77  1997 Codon-usage variants in the polymorphic (GGN)n trinucleotide repeat of the human androgen receptor gene. CAG, GGN, GGT
78  1997 Complete androgen insensitivity syndrome. Molecular characterization in two Chinese women. AIS
79  1997 Human androgen receptor expression in prostate cancer following androgen ablation. CAB
80  1996 Molecular biology of prostate cancer. CaP
81  1995 Characterization of alternative amino acid substitutions at arginine 830 of the androgen receptor that cause complete androgen insensitivity in three families. CAIS
82  1995 Characterization of normal and point-mutated human androgen receptors expressed in the baculovirus system. MB, MT
83  1995 Domains of the human androgen receptor and glucocorticoid receptor involved in binding to the nuclear matrix. hGR
84  1995 Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathies. polyGln
85  1995 Hormone-dependent transactivation by the human androgen receptor is regulated by a dnaJ protein. ---
86  1995 Mutated human androgen receptor gene detected in a prostatic cancer patient is also activated by estradiol. ---
87  1994 Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer. HR, PSA, SSCP
88  1994 Antiandrogens inhibit human androgen receptor-dependent gene transcription activation in the human prostate cancer cells LNCaP. Cypro.A, DHT, HO-FLU, MMTV-CAT
89  1994 Complete androgen insensitivity due to mutations in the probable alpha-helical segments of the DNA-binding domain in the human androgen receptor. ARE, DBD
90  1993 Growth factor regulation of gene expression in the human prostatic carcinoma cell line LNCaP. EGF, mRNAs
91  1993 Interaction of antiandrogen-androgen receptor complexes with DNA and transcription activation. ARE, Cypro.A, DHT, HO-FLU, MMTV-CAT
92  1993 Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy. ---
93  1993 Transcriptional and posttranscriptional regulation of human androgen receptor expression by androgen. ---
94  1993 Two different, overlapping pathways of transcription initiation are active on the TATA-less human androgen receptor promoter. The role of Sp1. ---
95  1992 Characterization of human androgen receptor overexpressed in the baculovirus system. ---
96  1992 Expression and characterization of full-length and partial human androgen receptor fusion proteins. Implications for the production and applications of soluble steroid receptors in Escherichia coli. GST, MMTV-LTR
97  1992 Point mutation in the steroid-binding domain of the androgen receptor gene in a family with complete androgen insensitivity syndrome (CAIS). CAIS
98  1992 Regulation of androgen receptor expression in the human heterotransplantable prostate carcinoma PC-82. mRNA
99  1992 The human androgen receptor: structure/function relationship in normal and pathological situations. AIS
100  1992 [Production of polyclonal antibody against human androgen receptor and immunohistochemical study of human androgen receptor in prostatic tissues]. ---